Literature DB >> 10425214

Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex.

J Zheng1, V D Ramirez.   

Abstract

Piceatannol is a stilbene phytochemical from the seeds of Euphorbia lagascae, previously identified as an antileukemic principle. Piceatannol is considered an inhibitor of several tyrosine kinases. We recently reported that resveratrol, another stilbene phytoalexin from grape seeds, was an inhibitor of ATP synthase. Here, we demonstrated that piceatannol potently inhibited the rat brain mitochondrial F0F1-ATPase activity in both solubilized and submitochondrial preparations (IC50 of 8-9 microM), while having relatively small effect on the Na(+), K(+)-ATPase activity of porcine cerebral cortex (no effect up to 7 microM). Piceatannol inhibited the ATPase activity of the purified rat liver F1 with IC50 of about 4 microM, while resveratrol was slightly less active (IC50 of about 14 microM). Our results indicate that piceatannol and resveratrol inhibit the F-type ATPase by targeting the F1 sector, which is located to the inner membrane of mitochondria and plasma membrane of normal endothelial cells and several cancer cell lines. This mechanism could potentially contribute to the multiple effects of these chemopreventive phytochemicals. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425214     DOI: 10.1006/bbrc.1999.1063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner.

Authors:  Nagababu Chinnam; Prasanna K Dadi; Shahbaaz A Sabri; Mubeen Ahmad; M Anaul Kabir; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2010-03-25       Impact factor: 6.953

Review 3.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

4.  Inhibition sites in F1-ATPase from bovine heart mitochondria.

Authors:  Jonathan R Gledhill; John E Walker
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

5.  An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.

Authors:  Nick R Burwick; Miriam L Wahl; Jun Fang; Zhaoxi Zhong; Tammy L Moser; Bo Li; Roderick A Capaldi; Daniel J Kenan; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

Review 6.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

7.  Effects of standardized extract of Ginkgo biloba leaves EGb761 on mitochondrial functions: mechanism(s) of action and dependence on the source of mitochondria and respiratory substrate.

Authors:  Giedre Baliutyte; Sonata Trumbeckaite; Rasa Baniene; Vilmante Borutaite; Adolfas Toleikis
Journal:  J Bioenerg Biomembr       Date:  2014-11-14       Impact factor: 2.945

8.  Mechanism of inhibition of mitochondrial ATP synthase by 17β-estradiol.

Authors:  António J M Moreno; Paula I Moreira; José B A Custódio; Maria S Santos
Journal:  J Bioenerg Biomembr       Date:  2012-12-29       Impact factor: 2.945

9.  Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain.

Authors:  J L Kipp; V D Ramirez
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

10.  Autoantibodies to endothelial cell surface ATP synthase, the endogenous receptor for hsp60, might play a pathogenic role in vasculatides.

Authors:  Jean-Eric Alard; Sophie Hillion; Loïc Guillevin; Alain Saraux; Jacques-Olivier Pers; Pierre Youinou; Christophe Jamin
Journal:  PLoS One       Date:  2011-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.